Status:
COMPLETED
Optic Nerve Compliance Study
Lead Sponsor:
Capital Vision Research Trust
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world. It is a condition where long term exposure to high eye pressures (intra-ocular pressure) damages the ...
Detailed Description
Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world (the following reference gives rate of visual impairment/blindness caused by glaucoma in one cross-sec...
Eligibility Criteria
Inclusion
- Age over 18, Diagnosis of glaucoma (visual field proven), Stable, well controlled glaucoma
Exclusion
- Previous eye surgery, Best corrected visual acuity \<6/9, Chronic eye disease (including glaucoma, Secondary glaucoma (eg uveitis, neovascular glaucoma, etc), Advanced or fixation-threatening visual field changes, Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00328835
Start Date
March 1 2006
End Date
April 1 2006
Last Update
October 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital Vision Research Trust
Wellington, New Zealand, 6001